Executives at iBio (NASDAQ:IBIO) outlined the scientific and strategic rationale for a myostatin/activin A bispecific antibody program that the company believes could become a next-generation therapy ...

Ferguson leaders and developers hosted a public forum to address concerns about the proposed development, framing it as an ...

DHAKA, March 20 (Reuters) - Bangladesh is seeking billions in external financing to secure fuel and liquefied natural gas ...

Lake Wylie neighbors know they can’t stop a massive data center from being built beside them. But they’re sounding off in the ...

Ocugen OCGN is building its ocular portfolio around a modifier gene therapy idea: instead of designing a therapy for a single genetic defect, the platform is intended to work across many underlying ...

People often seem to understand language before they have actually heard enough words to determine its structure. In everyday ...

India faces a shortage of eye specialists as vision problems rise. An expert explains how strengthening optometry and ...

The interest in more upscale hotels in downtown Columbia comes as luxury hotelier Kessler plans to build a Grand Bohemian ...

The Colorado Economic Development Commission Thursday offered incentives to a pair of unnamed companies — one in the aerospace and defense sectors and the other a medical-device manufacturer — that ...

Terry Corless, CEO of Mad Dogs Restaurant Group, is among the many business owners still recovering from the COVID-19 pandemic.

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye ...

A rendering shows a street-level view of the four-story townhomes. The proposal near the Bucks County border would replace a ...